Prolonged low-dose administration of the cyclooxygenase-2 inhibitor celecoxib enhances the antitumor activity of irinotecan against neuroblastoma xenografts-Reference-Cited by-同舟云学术

Prolonged low-dose administration of the cyclooxygenase-2 inhibitor celecoxib enhances the antitumor activity of irinotecan against neuroblastoma xenografts

Published:2009-11 Issue:11 Volume:100 Page:2193-2201
ISSN:1347-9032
Container-title:Cancer Science
language:en
Short-container-title:

Author:

Kaneko Michio,Kaneko Setsuko,Suzuki Kenshi

Publisher

Wiley

Subject

Cancer Research,Oncology,General Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1349-7006.2009.01280.x/fullpdf

Reference33 articles.

1. Successful treatment of chemoresistant stage 3 neuroblastoma using irinotecan as a single agent;Inagaki;J Pediatr Hematol Oncol,2005

2. Irinotecan for children with relapsed solid tumors;Shitara;Pediatr Hematol Oncol,2006

3. Irinotecan plus temozolomide for relapsed or refractory neuroblastoma;Kushner;J Clin Oncol,2006

4. Nonplatinum-based chemotherapy with irinotecan plus docetaxel for advanced or metastatic olfactory neuroblastoma: a retrospective analysis of 12 cases;Kiyota;Cancer,2008

5. Phase II trial of irinotecan in children with refractory solid tumors: a Children’s Oncology Group Study;Bomgaars;J Clin Oncol,2007

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Ferrocenyl Azoles: Versatile N‐Containing Heterocycles and their Anticancer Activities;The Chemical Record;2024-07

2. Prostaglandin E2 in neuroblastoma: Targeting synthesis or signaling?;Biomedicine & Pharmacotherapy;2022-12

3. Anti-Angiogenic Treatments Interact with Steroid Secretion in Inflammatory Breast Cancer Triple Negative Cell Lines;Cancers;2021-07-21

4. Targeting the COX/mPGES-1/PGE2 Pathway in Neuroblastoma;Advances in Experimental Medicine and Biology;2019

5. Design, synthesis and biological evaluation of novel ferrocene-pyrazole derivatives containing nitric oxide donors as COX-2 inhibitors for cancer therapy;European Journal of Medicinal Chemistry;2018-09